Biomedical Laboratory Science

ShareThis

Sunday, November 12, 2017

Siddhartha Equity Fund Allotment Concludes, Check Your Result Now!

Siddhartha Equity Fund has concluded its public issue allotment today at Siddhartha Capital Limited, Naxal, Kathmandu.

Applicants who had applied up to 8 lakh units (up to Rs 80 lakh) were allotted as much as they had applied for. Among 41 applicants who had applied 10 lakh units to 24 lakh units (Rs 1 crore to Rs 2.40 crore), 33 applicants were allotted 967,748 units each and 8 applicants were allotted 967,747 units each. The remaining 2.25 crore units were allotted to Siddhartha Bank as the fund sponsor.




Out of 29,573 applicants, 29,549 applicants were allotted. There were 24 invalid applicants.

Although Siddhartha Equity Fund had floated its public issue of 12 crore unit shares worth Rs 1.20 arba, the fund size was increased by 25% to Rs 1.50 arba due to oversubscription. SEF had floated public issue from Ashwin 25, 2074 to Ashwin 30, 2074. 15% units was reserved for Siddhartha Bank.




Siddhartha Equity Fund is a closed-end 10-years equity oriented mutual fund scheme with fund size of Rs 1.50 arba. The mutual fund is managed by Siddhartha Capital Limited and Siddhartha Bank Limited is its fund sponsor.



Siddhartha Capital already has its two mutual fund schemes named Siddhartha Investment Growth Scheme (SIGS1) and Siddhartha Equity Oriented Scheme (SEOS), and both are listed in NEPSE.




Siddhartha Equity Oriented Limited (SEOS) and Siddhartha Investment Growth Scheme-1 (SIGS1)—closed-end 5 years mutual fund schemes, SIGS1 and SEOS have reported net asset value (NAV) of Rs 21.55 and Rs 13.21 respectively in Ashwin 2074 end.

Check the link below to see the result at Sharesansar Site:




Check the link below to see the result at Bizpati Site:



Check the link below to see the result at Siddhartha Capital Site:





Check the link below to see all allottees list in excel format:



ShareUpdateNepal: Sunday 12th November 2017

Friday, November 10, 2017

Urinalysis Quality Control at the Point-of-Care !


The goal of any clinical diagnostic test procedure is to provide critical information in a timely manner so that appropriate actions may be taken, ultimately improving patient outcomes. Point-of-care testing (POCT) is a term that has come to describe a multitude of rapid medical tests that can be performed at or near the site of patient care. The most compelling benefit of these tests is that, as opposed to having to wait hours or days for results to arrive from an outside laboratory, clinicians can obtain the results immediately, allowing for clinical management decisions to be made while the patient is still at the care facility. While the implementation of rapid diagnostic tests dates back to ancient history (sweet-tasting urine was once commonly used to diagnose diabetes mellitus), it was not until the 1950s that these rapid diagnostic methods gained any real predictive value. Today, the popularity and demand for POCT are increasing rapidly. TriMark Publications estimates that the global market for POCT was $14.5 billion in 2016, and is expected to grow by seven percent over the next five years.




Urinalysis dipsticks at the point-of-care:


Urinalysis using multi-analyte dipsticks is a point-of-care test performed at any hospital, clinical laboratory, doctor’s office, health clinic, and nursing facility. Various iterations of these tests have existed for decades, and they continue to be among the most commonly performed tests of any kind. Urinalysis dipsticks contain discrete reagent pads to semi-quantitatively test for the presence of bilirubin, blood, creatinine, glucose, ketones, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen in a urine sample.






Practical Textbook of Biochemistry for Medical Students 2nd Edition !


Practical Textbook of Biochemistry for Medical Students 2nd Edition pdf







This book is in resonance with the Textbook of Biochemistry for Medical Students, by Vasudevan et al, which is now in the 7th edition. That textbook is now accepted not only inside India, but also various other countries in the world. The Spanish edition of the Textbook is already in market and a Russian edition is in preparation. Students are advised to clear the doubts by going through that main textbook. This practical book is prepared after consulting the syllabi of MBBS course of various universities. The contents are divided into qualitative and quantitative experiments, which the students are supposed to do by themselves in the practical classes. Further, a few more experiments are given, which may not be possible for the student to do by himself/herself. Some of these will be demonstrated in the practical classes. In the end, a few case reports are also included, which will be useful for the students to prepare the practical examinations.

Printed Pages: 162.
Bookseller Inventory # 95567

Editorial Reviews

Brand New Book in Perfect Condition.Fast Shipping with tracking number.


Product details

  • Paperback: 162 pages 
  • Publisher: Jp Medical Ltd; 2nd Revised ed. edition (July 1, 2013) 
  • Language: English 
  • ISBN-10: 9350906686 
  • ISBN-13: 978-9350906682


Thursday, November 9, 2017

Gut Bacteria And The Brain: Are We Controlled By Microbes?

Although the interaction between our brain and gut has been studied for years, its complexities run deeper than initially thought. It seems that our minds are, in some part, controlled by the bacteria in our bowels.


The gut has defenses against pathogens, but, at the same time, it encourages the survival and growth of "healthy" gut bacteria.

The vast majority of these single-celled visitors are based in the colon, where no less than 1 trillion reside in each gram of intestinal content.

Estimating the number of bacterial guests in our gut is challenging; to date, the best guess is that 40 trillion bacteria call our intestines home - partially dependent on the size of your last bowel movement (poop's major ingredient is bacteria).




How much sway can a microbe hold? Bacterial influence over human psychology is slowly coming
into focus.

Tuesday, November 7, 2017

Support Microfinance IPO Allotment by Lottery, 10 Kitta Shares to Elligible Applicants !

Support Microfinance Bittiya Sanstha Ltd. (SMFBL) has allocated its Initial Public Offering (IPO) today, Wednesday. According to NMB Capital Ltd., the issue manager of the microfinance, out of 226,932 applicants, only 16,740 applicants are allotted 10 units of mandatory shares through the lottery system.




Of the total 226,932 IPO share applications worthing Rs. 2.24 billion, 210,192 were canceled. The microfinance headquartered at Itahari issued 180,000 units of IPO shares to general public worth Rs. 18 million from 4th to 9th October 2017. The issuance was oversubscribed by 27.69 times.




Out of the total shares, the company allocated 3,600 units (2%) and 9000 units (5%) of shares for employees and mutual funds respectively.

As per the statistics provided by NMB Capital, only 7.38% of the total applicants are provided the shares.




Currently, the company has a paid-up capital of Rs. 42 million. After this IPO issuance, it will reach Rs. 60 million. The microfinance earned a net profit of Rs. 4.8 million in the last Fiscal Year (FY). The company has Rs. 3.119 million in its reserve fund.




Check the link below to see the result at MeroLagani Site:





Check the link below to see the result at ShareSansar Site:







Check the link below to see the result at Bizpati Site:








Check the link below to see the result at NMB Capital site:






Check the link below to see all allottees list in excel format:

IPO RESULT FULL ALLOTTEES LIST (excel)


Check the link below to see/download all allottees list in pdf format:





Check the link below to search if your name in the the non-allottees list:



ShareUpdateNepal: Wednesday 8th November 2017

Tuesday, October 31, 2017

Best Vitamins for Gastritis !

Gastritis is a condition where the inner lining of the stomach gets inflamed. It is often caused by consumption of excessive alcohol and even due to usage of anti-inflammatory drugs. It is mainly caused by the bacterial infections and several autoimmune disorders can lead to gastritis.


The symptoms of gastritis are indigestion, abdominal pain, nausea, vomiting and heartburn. Taking a multivitamin supplement is highly beneficial for those people suffering with gastritis. By eating a balanced diet and reducing stress, one can treat gastritis. Vitamins and minerals which function as antioxidant are best remedies to improve the digestive health.


Essential Vitamins For Gastritis

1. Vitamin C

Vitamin C is an essential nutrient for the functioning of several metabolic reactions in animals and plants. Since it cannot be produced in the body, vitamin C must be taken from foods. Vitamin C deficiency can cause scurvy in humans.


This vitamin helps the body to absorb calcium and iron salts in the body. And they help to aggravate the digestive process and can reduce the irritation in the inner lining of the stomach. People who take vitamin C can control and cure gastritis. Vitamin C is present in a variety of foods and some of them are oranges, guavas, green peppers, parsley, broccoli and papayas.

2. Vitamin A

Vitamin A plays an important role in many functions that take place in our body. It also functions as retinoic acid, which is an essential hormone required for growth of epithelial cells. Vitamin A is required for various intrinsic processes.


It helps in promoting vision and enhances immune system functioning. Beta-carotene which is a precursor of vitamin A is an antioxidant, that can be obtained from many foods. It is recommended to take vitamin A in small doses and foods that rich in vitamin A are sweet potatoes, carrots, milk, paprika, turnips, lettuce and apricots.

3. Vitamin B6

Vitamin B6 is a water soluble vitamin, which helps in the functioning of several enzymatic reactions. It is also involved in different metabolisms and synthesis of hemoglobin. Pyridoxal phosphate is the active form of vitamin B6 to act as a co-enzyme with other enzymes that are particularly involved in metabolic activities.


Vitamin B6 is also an antioxidant, helps in controlling the levels of homocysteine and improves digestive functioning. The food sources that are having vitamin B6 are avocados, meat, nuts, poultry, whole grains, bananas and legumes.

4. Vitamin B12

Vitamin B12 is an important vitamin that functions the nervous system and helps in the formation of blood. It is a part of the B vitamins and is water soluble. Vitamin B12 is also required to make DNA and the genetic material in the cells.


Naturally vitamin B12 is bound to the proteins and only when the stomach releases hydrochloric acid, vitamin B12 gets separated. People with gastritis needs to take high doses of vitamin B12 to get absorbed properly. Foods that are rich in vitamin B12 are oysters, liver, octopus, crab, beef, cheese and fish.

5. Vitamin E

Vitamin E is a fat soluble compound required for many biological functions. It is an antioxidant which prevents accumulation of the free radicals in the tissues. It can be easily propagated into cell membranes to protect them from oxidation damage.


Vitamin E helps in soothing the stomach and periodically heals the lining of the stomach. By taking vitamin E as a part of the diet, one can reduce the inflammation and cure the gastritis. Foods that are rich in vitamin E are almonds, pine nuts, sunflower seeds, basil, apricots and peanuts.

Monday, October 23, 2017

First Microfinance Again First to Publish First Quarterly Report of FY 2074/075; Earnings Surge by 60.44% to Rs. 24.13 Million !

First Microfinance Development Bank Ltd. (FMDBL) is again the first among the publishing companies to publish its provisional financial statement from the (Q1) of the fiscal year (FY) 2074/075, with an impressive profit growth of 60.44%.


According to the unaudited financial report for Q1 published yesterday, the microfinance has stated that its net profit surged to Rs. 24.13 million in Q1 as compared to Rs. 15 million in the corresponding Q1 of the last FY 2073/074.

The borrowing of the microfinance has increased from Rs 32.2 billion in the corresponding Q1 of the previous year to Rs. 35.2 billion in the Q1 of the current FY 2074/075.

Its net interest income has also increased to Rs. 40.8 million in the Q1 up from Rs. 26.5 million compared to the corresponding Q1 of the last fiscal year. The microfinance company has an operating profit of Rs. 37.9 million in Q1 of the ongoing FY.

The paid up capital of the company stands at Rs. 456.2 million in Q1 of FY 2074/075. Its reserve and surplus surges to Rs. 96 million in Q1 from Rs. 56.9 million in the corresponding Q1 of last FY.

It’s earnings per share (EPS) stands at Rs. 25.15; net worth per share at Rs. 121.05 and price to earnings (P/E) ratio at Rs. 39.75 times.

Check the LINK below to see current Financial ReportCompany Analysis and Progress Details of this Microfinance:





StockNewsNepal: Monday 23rd 2017
Related Posts Plugin for WordPress, Blogger...

AddToAny